Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huai-Xiang Hao

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
IUBMB Life|March 18, 2008
The role of PAS kinase in regulating energy metabolismHuai-Xiang Hao, Jared Rutter
Cancers|June 25, 2016
Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in CancerHuai-Xiang Hao, Xiaomo Jiang, Feng Cong
Experimental & Molecular Medicine|November 25, 2020
FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinomaHung Huynh, Aldo Prawira, Thi Bich Uyen Le, et al.
Oncotarget|June 2, 2020
Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcomaWen Luo, Changxin Xu, Sarah Phillips, et al.
Hepatology (Baltimore, Md.)|December 22, 2018
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular CarcinomaHung Huynh, Liek Yeow Lee, Kah Yong Goh, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2007
PAS kinase is required for normal cellular energy balanceHuai-Xiang Hao, Caleb M Cardon, Wojtek Swiatek, et al.
Biochemical and Biophysical Research Communications|July 20, 2010
Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localizationRong An, Gabriela da Silva Xavier, Francesca Semplici, et al.
Oncotarget|February 21, 2020
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFRHengyu Lu, Chen Liu, Hung Huynh, et al.
Journal of Translational Medicine|September 14, 2018
Differential responses of MET activations to MET kinase inhibitor and neutralizing antibodyJianqun Kou, Phillip R Musich, Ben Staal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2019
Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET ActivationSabrina Baltschukat, Barbara Schacher Engstler, Alan Huang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
IUBMB Life|March 18, 2008
The role of PAS kinase in regulating energy metabolismHuai-Xiang Hao, Jared Rutter
Cancers|June 25, 2016
Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in CancerHuai-Xiang Hao, Xiaomo Jiang, Feng Cong
Experimental & Molecular Medicine|November 25, 2020
FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinomaHung Huynh, Aldo Prawira, Thi Bich Uyen Le, et al.
Oncotarget|June 2, 2020
Protein phosphatase 1 regulatory subunit 1A regulates cell cycle progression in Ewing sarcomaWen Luo, Changxin Xu, Sarah Phillips, et al.
Hepatology (Baltimore, Md.)|December 22, 2018
Infigratinib Mediates Vascular Normalization, Impairs Metastasis, and Improves Chemotherapy in Hepatocellular CarcinomaHung Huynh, Liek Yeow Lee, Kah Yong Goh, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2007
PAS kinase is required for normal cellular energy balanceHuai-Xiang Hao, Caleb M Cardon, Wojtek Swiatek, et al.
Biochemical and Biophysical Research Communications|July 20, 2010
Pancreatic and duodenal homeobox 1 (PDX1) phosphorylation at serine-269 is HIPK2-dependent and affects PDX1 subnuclear localizationRong An, Gabriela da Silva Xavier, Francesca Semplici, et al.
Oncotarget|February 21, 2020
Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFRHengyu Lu, Chen Liu, Hung Huynh, et al.
Journal of Translational Medicine|September 14, 2018
Differential responses of MET activations to MET kinase inhibitor and neutralizing antibodyJianqun Kou, Phillip R Musich, Ben Staal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2019
Capmatinib (INC280) Is Active Against Models of Non-Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET ActivationSabrina Baltschukat, Barbara Schacher Engstler, Alan Huang, et al.
Pageof 3